Bio Green Med Solution, Inc. — Director's Dealing 2009

Oct 9, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2009-10-08

Reporting Person: MARXE AUSTIN W & GREENHOUSE DAVID M (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-10-08	Common Stock	P	1000	$0.84	Acquired	3992624	Indirect

Footnotes

F1: This is a joint filing by Austin W. Marxe (Marxe) and David M. Greenhouse (Greenhouse). They share voting and investment control over all securities owned by Special Situations Fund III QP, L.P. (QP), Special Situations Private Equity Fund, L.P. (PE) and Special Situations Life Sciences Fund, L.P. (LS), respectively. 2,575,242 shares of Common Stock are held by QP, 643,809 shares of Common Stock are held by PE and 773,573 shares of Common Stock are held by LS. The interest of Marxe and Greenhouse in the shares of Common Stock owned by QP, PE and LS is limited to the extent of his pecuniary interest.